Guided Surgery for Dental Implants in Partially Edentulous Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new dental device called PrimeTaper EV for individuals needing one or more teeth replaced with implants and seeking quick restoration. The goal is to evaluate the device's effectiveness for those with a healed area in their mouth or requiring teeth extraction and replacement with implants. Ideal participants have stable teeth or dentures in the opposing jaw and desire immediate loading of the implants. This trial may suit those missing teeth and seeking a fast solution. As an unphased trial, it offers participants the chance to contribute to innovative dental solutions and potentially benefit from a rapid restoration process.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those using systemic corticosteroids, IV bisphosphonates, or any medication that could affect healing. It's best to discuss your specific medications with the trial team.
What prior data suggests that this dental device is safe for use in guided surgery for dental implants?
Research has shown that the PrimeTaper EV dental implant is generally well-tolerated. The FDA has already approved it for dental use, indicating its safety. Over five years, dentists have provided positive feedback on its ease of placement and the results it delivers. No major reports of serious side effects have emerged, and it has proven effective for those needing tooth replacements. This history supports the safety of the PrimeTaper EV implant for use in humans.12345
Why are researchers excited about this trial?
Researchers are excited about the PrimeTaper EV treatment because it offers a new approach to dental implants for partially edentulous patients. Unlike traditional methods that rely on freehand surgery, PrimeTaper EV uses guided surgery, which provides greater precision and accuracy during the implant placement process. This can potentially lead to better outcomes, such as improved implant stability and reduced recovery time. By enhancing the accuracy of implant positioning, PrimeTaper EV aims to improve patient satisfaction and long-term success rates compared to conventional techniques.
What evidence suggests that the PrimeTaper EV dental implant is effective for dental implants in partially edentulous patients?
Research has shown that the PrimeTaper EV dental implant achieves high success rates and patient satisfaction. One study found it performed well for at least three years. This implant suits individuals needing to replace one or more missing teeth. It allows for immediate restoration, enabling the new tooth to be placed right away. Overall, evidence supports its effectiveness in assisting those with missing teeth.23678
Are You a Good Fit for This Trial?
This trial is for adults over 25 needing dental implants where immediate loading is preferred. They must have stable occlusion with dentures, bridges, crowns, or natural teeth and sign a consent form. Excluded are those needing major bone grafts, with uncontrolled oral diseases or systemic conditions affecting healing, heavy smokers, pregnant women, recent chemotherapy or radiation patients in the head/neck area.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive PrimeTaper EV implants using non-guided or guided surgical techniques
Follow-up
Participants are monitored for implant survival, success, and patient-reported outcomes
What Are the Treatments Tested in This Trial?
Interventions
- PrimeTaper EV
PrimeTaper EV is already approved in United States for the following indications:
- Single tooth replacement
- Multiple tooth replacement
- Immediate restoration/loading in partially edentulous patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGuire Institute
Lead Sponsor
Dentsply Sirona Implants and Consumables
Industry Sponsor
Simon Campion
Dentsply Sirona Implants and Consumables
Chief Executive Officer since 2022
PhD in Chemistry from Texas A&M University
Dr. Patrizia Cavazzoni
Dentsply Sirona Implants and Consumables
Chief Medical Officer
MD from Harvard Medical School
Dentsply Sirona Implants
Industry Sponsor
Simon Campion
Dentsply Sirona Implants
Chief Executive Officer since 2022
PhD in Chemistry from Texas A&M University
Dr. David Ferguson
Dentsply Sirona Implants
Chief Medical Officer
MD from Harvard Medical School